Antidepressive effects and enhanced wakefulness were observed with OX2R activation in established animal model of major depressive disorderBOSTON and LONDON, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Centessa ...
Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI), ...
BiLSTM, an ICD-11 automatic coding model using MC-BERT and label attention. Experiments on clinical records show 83.86% ...
KOLKATA: The 10th International Conference on Data Management, Analytics and Innovation (ICDMAI 2026) concluded on Saturday ...
Detailed price information for Jade Biosciences Inc (JBIO-Q) from The Globe and Mail including charting and trades.
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...
As Finance Minister Nirmala Sitharaman prepares to present her ninth Budget, expectations centre on a consumption-led growth ...
Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity ...
New Drug Application (NDA) for NonAdvSM submitted in December 2025, NDA submission for AdvSM on track for 1H 2026NDA submission for GIST on track ...
2d
ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones
Financial Guidance As of September 30, 2025, cash, cash equivalents and investments totaled $413.0 million, which the company expects will be sufficient to fund its operating plan into 2H 2028, beyond ...
(GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating ...
Detailed price information for Molecular Partners Ag ADR (MOLN-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback